Title |
Of Men and Mice: Modeling the Fragile X Syndrome
|
---|---|
Published in |
Frontiers in Molecular Neuroscience, March 2018
|
DOI | 10.3389/fnmol.2018.00041 |
Pubmed ID | |
Authors |
Regina Dahlhaus |
Abstract |
The Fragile X Syndrome (FXS) is one of the most common forms of inherited intellectual disability in all human societies. Caused by the transcriptional silencing of a single gene, the fragile x mental retardation gene FMR1, FXS is characterized by a variety of symptoms, which range from mental disabilities to autism and epilepsy. More than 20 years ago, a first animal model was described, the Fmr1 knock-out mouse. Several other models have been developed since then, including conditional knock-out mice, knock-out rats, a zebrafish and a drosophila model. Using these model systems, various targets for potential pharmaceutical treatments have been identified and many treatments have been shown to be efficient in preclinical studies. However, all attempts to turn these findings into a therapy for patients have failed thus far. In this review, I will discuss underlying difficulties and address potential alternatives for our future research. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Australia | 1 | 33% |
Japan | 1 | 33% |
Unknown | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 67% |
Scientists | 1 | 33% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 216 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 39 | 18% |
Student > Bachelor | 30 | 14% |
Student > Ph. D. Student | 28 | 13% |
Student > Master | 24 | 11% |
Student > Doctoral Student | 11 | 5% |
Other | 22 | 10% |
Unknown | 62 | 29% |
Readers by discipline | Count | As % |
---|---|---|
Neuroscience | 53 | 25% |
Agricultural and Biological Sciences | 28 | 13% |
Biochemistry, Genetics and Molecular Biology | 22 | 10% |
Medicine and Dentistry | 12 | 6% |
Psychology | 11 | 5% |
Other | 25 | 12% |
Unknown | 65 | 30% |